|
SRP19 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.136200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.307800E-01 |
| Normal-vs-Stage2 |
8.257800E-01 |
| Normal-vs-Stage3 |
5.372300E-02 |
| Normal-vs-Stage4 |
1.268980E-01 |
| Stage1-vs-Stage2 |
7.207600E-01 |
| Stage1-vs-Stage3 |
3.950000E-02 |
| Stage1-vs-Stage4 |
1.130400E-01 |
| Stage2-vs-Stage3 |
1.015410E-01 |
| Stage2-vs-Stage4 |
1.639780E-01 |
| Stage3-vs-Stage4 |
8.239600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.895800E-01 |
| Normal-vs-AfricanAmerican |
5.735800E-01 |
| Normal-vs-Asian |
1.381750E-01 |
| Caucasian-vs-AfricanAmerican |
6.633200E-01 |
| Caucasian-vs-Asian |
1.440600E-01 |
| AfricanAmerican-vs-Asian |
1.598000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.470800E-01 |
| Normal-vs-Female |
7.041800E-02 |
| Male-vs-Female |
1.276200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.661800E-01 |
| Normal-vs-Extreme_Weight |
6.752000E-01 |
| Normal-vs-Obese |
9.302400E-01 |
| Normal-vs-Extreme_Obese |
3.422000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.545400E-01 |
| Normal_Weight-vs-Obese |
5.015000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.192800E-01 |
| Extreme_Weight-vs-Obese |
7.549000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.078400E-01 |
| Obese-vs-Extreme_Obese |
4.255400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.473200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.466790E-01 |
| Normal-vs-Age(61-80Yrs) |
5.258600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.432800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.279000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.649600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.018400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.451730E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.593400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.494000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.153000E-01 |
| Normal-VS-Type2 PRCC |
1.223770E-01 |
| Normal-VS-KIRP CIMP |
6.611400E-01 |
| Normal-VS-Unclassified PRCC |
8.455800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.298300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.521200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.218400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.091600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.238800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.777000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.674400E-01 |
| Normal-vs-N1 |
1.084290E-02 |
| Normal-vs-N2 |
8.879600E-01 |
| N0-vs-N1 |
1.233530E-02 |
| N0-vs-N2 |
8.420600E-01 |
| N1-vs-N2 |
2.347400E-01 |
|
|
